These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 29107736)

  • 1. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
    Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice.
    Starczak Y; Reinke DC; Barratt KR; Russell PK; Clarke MV; Davey RA; Atkins GJ; Anderson PH
    J Steroid Biochem Mol Biol; 2021 Jun; 210():105857. PubMed ID: 33647520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms involved in bone resorption regulated by vitamin D.
    Nakamichi Y; Udagawa N; Suda T; Takahashi N
    J Steroid Biochem Mol Biol; 2018 Mar; 177():70-76. PubMed ID: 29146302
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice.
    Reinke DC; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
    J Steroid Biochem Mol Biol; 2016 Nov; 164():353-360. PubMed ID: 26639637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
    Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
    Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inferences from genetically modified mouse models on the skeletal actions of vitamin D.
    Goltzman D
    J Steroid Biochem Mol Biol; 2015 Apr; 148():219-24. PubMed ID: 25237033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired bone resorption in cathepsin K-deficient mice is partially compensated for by enhanced osteoclastogenesis and increased expression of other proteases via an increased RANKL/OPG ratio.
    Kiviranta R; Morko J; Alatalo SL; NicAmhlaoibh R; Risteli J; Laitala-Leinonen T; Vuorio E
    Bone; 2005 Jan; 36(1):159-72. PubMed ID: 15664014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice.
    Reinke DC; Starczak Y; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
    J Steroid Biochem Mol Biol; 2018 Mar; 177():96-102. PubMed ID: 28765041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.
    Ormsby RT; Findlay DM; Kogawa M; Anderson PH; Morris HA; Atkins GJ
    J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():110-3. PubMed ID: 24120913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitamin D hormone inhibits osteoclastogenesis in vivo by decreasing the pool of osteoclast precursors in bone marrow.
    Shibata T; Shira-Ishi A; Sato T; Masaki T; Masuda A; Hishiya A; Ishikura N; Higashi S; Uchida Y; Saito MO; Ito M; Ogata E; Watanabe K; Ikeda K
    J Bone Miner Res; 2002 Apr; 17(4):622-9. PubMed ID: 11918219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phlpp1 is induced by estrogen in osteoclasts and its loss in Ctsk-expressing cells does not protect against ovariectomy-induced bone loss.
    Hanson MK; Karkache IY; Molstad DHH; Norton AA; Mansky KC; Bradley EW
    PLoS One; 2021; 16(6):e0251732. PubMed ID: 34143773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulation of osteoclast formation by 1,25-dihydroxyvitamin D requires its binding to vitamin D receptor (VDR) in osteoblastic cells: studies using VDR knockout mice.
    Takeda S; Yoshizawa T; Nagai Y; Yamato H; Fukumoto S; Sekine K; Kato S; Matsumoto T; Fujita T
    Endocrinology; 1999 Feb; 140(2):1005-8. PubMed ID: 9927335
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The vitamin D receptor functions as a transcription regulator in the absence of 1,25-dihydroxyvitamin D
    Lee SM; Pike JW
    J Steroid Biochem Mol Biol; 2016 Nov; 164():265-270. PubMed ID: 26323657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nongenomic effects of 1α,25-dihydroxyvitamin D
    Hirota Y; Nakagawa K; Mimatsu S; Sawada N; Sakaki T; Kubodera N; Kamao M; Tsugawa N; Suhara Y; Okano T
    Biochem Biophys Res Commun; 2017 Jan; 483(1):359-365. PubMed ID: 28025137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteoclast-specific cathepsin K deletion stimulates S1P-dependent bone formation.
    Lotinun S; Kiviranta R; Matsubara T; Alzate JA; Neff L; Lüth A; Koskivirta I; Kleuser B; Vacher J; Vuorio E; Horne WC; Baron R
    J Clin Invest; 2013 Feb; 123(2):666-81. PubMed ID: 23321671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A High-Calcium and Phosphate Rescue Diet and VDR-Expressing Transgenes Normalize Serum Vitamin D Metabolite Profiles and Renal Cyp27b1 and Cyp24a1 Expression in VDR Null Mice.
    Kaufmann M; Lee SM; Pike JW; Jones G
    Endocrinology; 2015 Dec; 156(12):4388-97. PubMed ID: 26441239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Fos protein as a target of anti-osteoclastogenic action of vitamin D, and synthesis of new analogs.
    Takasu H; Sugita A; Uchiyama Y; Katagiri N; Okazaki M; Ogata E; Ikeda K
    J Clin Invest; 2006 Feb; 116(2):528-35. PubMed ID: 16424941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
    Ishizuka S; Kurihara N; Reddy SV; Cornish J; Cundy T; Roodman GD
    Endocrinology; 2005 Apr; 146(4):2023-30. PubMed ID: 15618361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Talin1 and Rap1 are critical for osteoclast function.
    Zou W; Izawa T; Zhu T; Chappel J; Otero K; Monkley SJ; Critchley DR; Petrich BG; Morozov A; Ginsberg MH; Teitelbaum SL
    Mol Cell Biol; 2013 Feb; 33(4):830-44. PubMed ID: 23230271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VDR in Osteoblast-Lineage Cells Primarily Mediates Vitamin D Treatment-Induced Increase in Bone Mass by Suppressing Bone Resorption.
    Nakamichi Y; Udagawa N; Horibe K; Mizoguchi T; Yamamoto Y; Nakamura T; Hosoya A; Kato S; Suda T; Takahashi N
    J Bone Miner Res; 2017 Jun; 32(6):1297-1308. PubMed ID: 28177161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.